Why the study?
The 6-minute walk distance test is a useful prognostic tool in chronic heart failure, but its usefulness after percutaneous coronary intervention is unknown.
Does the 6-minute walk distance test predict major adverse cardiovascular events in patients undergoing percutaneous coronary intervention?
Population
212 patients undergoing percutaneous coronary intervention
Comparison
6-minute walk distance test within 2 weeks after PCI
Design
Prospective observational study
Follow-up
one year
Authors
Loading...
Post-PCI 6MWD was associated with 1-year MACE; hypothesis-generating and requires validation before informing risk stratification.
Does the 6-minute walk distance test predict major adverse cardiovascular events in patients undergoing percutaneous coronary intervention?
The 6-minute walk distance test performed within 2 weeks after PCI is a reasonably good predictor of MACE and heart failure admission at one year, particularly in patients with a history of heart failure.
Dasari et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: